Mark Oyama

Mark Oyama is Professor and Chair of the Department of Clinical Sciences & Advanced Medicine at the University of Pennsylvania School of Veterinary Medicine, holding the Charlotte Newton Sheppard Endowed Chair of Medicine. He also serves as Associate Scholar at the Center for Clinical Epidemiology and Biostatistics (Perelman School of Medicine) and practices cardiology at the Ryan Veterinary Hospital, specializing in cardiac examinations, echocardiograms, ECG, and both non-invasive and invasive cardiac surgeries.

His educational background includes:

• DVM from University of Illinois (1994)
• Small Animal Internship at Animal Medical Center, New York (1994-1995)
• Cardiology Residency at University of California Davis (1995-1997)
• MSCE in Clinical Epidemiology from University of Pennsylvania (2015)

He is a Diplomate of the American College of Veterinary Internal Medicine (Cardiology).

Dr. Oyama's research spans cardiac biomarkers (troponin, natriuretic peptides), diuretic resistance mechanisms, clinical trial design, serotonin signaling in valvular disease, animal heart failure models, and epidemiological methodology. His primary focus is translational cardiology in canine and feline patients, particularly myxomatous mitral valve disease and degenerative cardiac conditions, with emphasis on molecular pathways and therapeutic interventions.

Analysis of his recent publications (2021-2025) reveals intensified investigation into metabolomics and gut microbiome interactions in heart disease, serotonin-based molecular mechanisms in mitral regurgitation, and innovative clinical trial frameworks like ORCA and EPIC. His work increasingly bridges veterinary and human cardiovascular research, exploring novel applications of SGLT2 inhibitors and advanced biomarker quantification for heart failure management.

No scientific awards were explicitly mentioned in the provided text.

As department chair and faculty member, Dr. Oyama mentors veterinary students and cardiology residents. His research is driven by major clinical trials (EPIC, PROTECT) and registry studies (VetCOT), often funded through institutional and collaborative grants with pharmaceutical partners and veterinary research consortia.

He operates within the Ryan Veterinary Hospital Cardiology Service and leverages resources from the Center for Clinical Epidemiology and Biostatistics, collaborating with Perelman School of Medicine researchers and international veterinary cardiology networks to advance evidence-based approaches in animal heart disease.